TrialClinical and translational science2020

A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects.

Azra Hussaini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.